# Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

> **NCT03755804** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 232 (actual)

## Conditions studied

- Hodgkin Lymphoma

## Interventions

- **DRUG:** bendamustine
- **DRUG:** Etoposide
- **DRUG:** Doxorubicin
- **DRUG:** Bleomycin
- **DRUG:** Vincristine
- **DRUG:** Vinblastine
- **DRUG:** Prednisone
- **DRUG:** Filgrastim
- **DRUG:** Brentuximab Vedotin
- **DRUG:** Cyclophosphamide
- **DRUG:** DTIC
- **OTHER:** Quality of Life Measurements
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT03755804
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-12-12
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755804, "Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03755804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*